Combination Therapies and Personalized Medicine
Proteomics
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 3, 2025

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
1Clinical Neuroproteomics Unit, Navarrabiomed, Hospitalario Universitario de Navarra (HUN), Navarra Institute for Health Research, Universidad Pública de Navarra (UPNA), IdiSNA, Irunlarrea 3, 31008 Pamplona, Spain.
Next-generation proteomics enables biomedical proteome research to identify disease-specific protein expression profiles. This approach aids in understanding disease mechanisms and discovering potential biomarkers for early detection and targeted therapies.
Area of Science:
Background:
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018